Caplin Point Laboratories Cash Flow Annual

BSE: 524742 | NSE: CAPLIPOINT | ISIN: INE475E01026 | Sector: Biotechnology & Drugs
2,195.00 -89.65 (-3.92%)Updated : 23 May 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Net Income/ Starting Line 676.78564.43451.35385.82
Depreciation/ Depletion 65.9653.4444.9946.90
Non- Cash Items -60.45-51.04-33.22-16.46
Changesin Working Capital -249.92-248.44-191.75-79.51
Cashfrom Operating Activities 432.37318.39271.37336.75
Capital Expenditures -191.52-145.82-193.47-91.18
Other Investing Cash Flow Items Total -143.21-174.22-24.11-179.76
Cashfrom Investing Activities -334.73-320.04-217.58-270.94
Financing Cash Flow Items -0.61-0.78-0.78-1.46
Total Cash Dividends Paid -37.99-34.17-30.32-22.69
Issuance( Retirement)of Stock Net 0.010.010.02-
Issuance( Retirement)of Debt Net 0.27-3.132.91-16.56
Cashfrom Financing Activities -38.32-38.07-28.17-40.71
Foreign Exchange Effects 1.430.861.18-0.09
Net Changein Cash 60.75-38.8626.8025.01
Cash Interest Paid 0.610.780.780.70
Cash Taxes Paid 130.60109.0088.0081.50
period Length 12.0012.0012.0012.00
period Type ----
*All figures in crores except per share values
Recommended For You
Trending Stocks
436.30+10.20(2.39%)
2,413.50+50.65(2.14%)